This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| AVEVA GROUP PLC | 3,690.0 | 3.2% |
| RELX PLC | 1,886.0 | 2.9% |
| RENTOKIL INITIAL PLC | 443.9 | 2.8% |
| SAGE GROUP PLC/THE | 677.8 | 2.6% |
| HALMA PLC | 1,990.0 | 2.2% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| TUI AG-DI | 841.6 | -4.6% |
| EVRAZ PLC | 497.9 | -3.9% |
| MONDI PLC | 1625.0 | -3.0% |
| SMURFIT KAPPA GROUP PLC | 2528.0 | -3.0% |
| BARCLAYS PLC | 149.2 | -2.8% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 7,320 | 0.0% | 0.3% |
| DOW JONES INDUS. AVG | 27,111 | 0.1% | 3.3% |
| DAX INDEX | 12,373 | -0.1% | 1.8% |
| NIKKEI 225 | 21,961 | -0.2% | -6.1% |
| S&P/ASX 200 INDEX | 6,682 | -0.2% | 8.4% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 59.18 | -0.27% |
| Brent Crude (ICE) | USD/bbl. | 64.70 | 0.23% |
| Gold Spot | USD/t oz. | 1,501 | 0.0% |
| Copper (Comex) | USd/lb. | 263 | 0.1% |
Click graph to enlarge
UK 100 Called to open down 10 points at 7310; This comes on the back of a positive trading session stateside seeing an all green board at close of US bourses. Although modest gains, further evidence of positive investor sentiment. It was a mixed session in Asia with the Nikkei closing negative (Albeit on -.18%) and the Hang Seng more positive (But only by 1 point). In focus today will be oil prices and oil miners after Saudi Arabia restored almost half the output lost at the Abqaiq plant, which is processing about 2 million barrels a day. The facility will return to pre-attack levels by the end of the month. Also in focus will be the FED interest rate decision today where the Fed are set to cut rates and prepare for a second cash blast. Oil retraced from Sunday nights highs once more to settle at $65 a barrel. Gold found support above $1500 once more.
AstraZeneca amends collaboration with Ironwood for Linzess in China, which will give them full responsibility for developing, manufacturing and commercialising the treatment for Irritable Bowel Syndrome.
Kingfisher reported H1 2019 profit of -6.4%, mainly hurt by the weak performance of its French operation. Underlying pre-tax profit of £353m million pounds against average analyst forecast of £342m (2018: £377m). Outlook remained mixed, highlighting continued uncertainty around UK consumer demand.
Pendragon report that H1 2019 has been challenging for the group with a loss before tax of £32.2m (2018: £28.4m profit), and no dividend proposed for FY 2019. Heightened political and Brexit uncertainty is adversely affecting customer confidence. They expect no improvements in market conditions and expect it to be challenging during second half of 2019.
Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal
Mediclinic Downgraded to Reduce by HSBC (Bloomberg: 7 Buys/ 7 Holds/ 1 Sell)
Weir Group Downgraded to Neutral by JP Morgan (Bloomberg: 15 Buys/ 5 Holds/ 0 Sells)
UK Retail Price Index data
UK Producer Price Index data
UK Consumer Price Index data
FED Interest Rate Decision
EU Consumer Price Index
Kingfisher, Pendragon, Rockhopper
Next, Clinigen, Kier Group, Smiths Group, IG Group, Saga, Sound Energy
Investec, Hurricane Energy
(Full list available on Week in advance)
Crest Nicholson - 3.1%
BCA Marketplace - 2.8%
Petrofac - 2.5%
Drax Group - 2.4%
(Full list available on Week in advance)
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.